Bile Duct Cancer Cholangiocarcinoma Global Clinical Trials Review, H1, 2015

Bile Duct Cancer Cholangiocarcinoma Global Clinical Trials Review, H1, 2015


  • Products Id :- GDHC2564CTIDB
  • |
  • Pages: 90
  • |
  • |
  • |
  Request for Sample Report
  Request A Quote

Executive Summary

Bile Duct Cancer (Cholangiocarcinoma) Global Clinical Trials Review, H1, 2015

GlobalData's clinical trial report, "Bile Duct Cancer (Cholangiocarcinoma) Global Clinical Trials Review, H1, 2015" provides data on the Bile Duct Cancer (Cholangiocarcinoma) clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Bile Duct Cancer (Cholangiocarcinoma). It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Bile Duct Cancer (Cholangiocarcinoma). This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each

Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type

Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons To Buy

Understand the dynamics of a particular indication in a condensed manner

Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more

Obtain discontinued trial listing for trials across the globe

Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies



Read More



Contact Us:
Ken Research
Ankur Gupta, Head Marketing & Communications

+91-9015378249

Table of Contents

Table of Contents 2

List of Tables 4

List of Figures 5

Introduction 6

Bile Duct Cancer (Cholangiocarcinoma) 6

Report Guidance 6

Clinical Trials by Region 7

Clinical Trials and Average Enrollment by Country 8

Top Five Countries Contributing to Clinical Trials in Asia-Pacific 10

Top Five Countries Contributing to Clinical Trials in Europe 11

Top Countries Contributing to Clinical Trials in North America 12

Top Countries Contributing to Clinical Trials in Middle East and Africa 13

Top Countries Contributing to Clinical Trials in Central and South America 14

Clinical Trials by G7 Countries: Proportion of Bile Duct Cancer (Cholangiocarcinoma) to Oncology Clinical Trials 15

Clinical Trials by Phase in G7 Countries 16

Clinical Trials in G7 Countries by Trial Status 17

Clinical Trials by E7 Countries: Proportion of Bile Duct Cancer (Cholangiocarcinoma) to Oncology Clinical Trials 18

Clinical Trials by Phase in E7 Countries 19

Clinical Trials in E7 Countries by Trial Status 20

Clinical Trials by Phase 21

In Progress Trials by Phase 22

Clinical Trials by Trial Status 23

Clinical Trials by End Point Status 24

Unaccomplished Trials of Bile Duct Cancer (Cholangiocarcinoma) 25

Subjects Recruited Over a Period of Time 30

Clinical Trials by Sponsor Type 31

Prominent Sponsors 32

Top Companies Participating in Bile Duct Cancer (Cholangiocarcinoma) Therapeutics Clinical Trials 33

Prominent Drugs 34

Latest Clinical Trials News on Bile Duct Cancer (Cholangiocarcinoma) 35

Nov 28, 2014: Concordia Healthcare Provides Clinical Trial And Corporate Update 35

Clinical Trial Profiles 36

Clinical Trial Overview of Top Companies 36

Sanofi 36

Clinical Trial Overview of Sanofi 36

Eli Lilly and Company 37

Clinical Trial Overview of Eli Lilly and Company 37

AstraZeneca PLC 38

Clinical Trial Overview of AstraZeneca PLC 38

GlaxoSmithKline plc 39

Clinical Trial Overview of GlaxoSmithKline plc 39

OncoTherapy Science, Inc. 40

Clinical Trial Overview of OncoTherapy Science, Inc. 40

Daiichi Sankyo Company, Limited 41

Clinical Trial Overview of Daiichi Sankyo Company, Limited 41

CellAct Pharma GmbH 42

Clinical Trial Overview of CellAct Pharma GmbH 42

C. H. Boehringer Sohn AG & Co. KG 43

Clinical Trial Overview of C. H. Boehringer Sohn AG & Co. KG 43

Astellas US Holding, Inc. 44

Clinical Trial Overview of Astellas US Holding, Inc. 44

Agios Pharmaceuticals, Inc. 45

Clinical Trial Overview of Agios Pharmaceuticals, Inc. 45

Clinical Trial Overview of Top Institutes / Government 46

National Cancer Institute 46

Clinical Trial Overview of National Cancer Institute 46

Massachusetts General Hospital 49

Clinical Trial Overview of Massachusetts General Hospital 49

Memorial Sloan Kettering Cancer Center 50

Clinical Trial Overview of Memorial Sloan Kettering Cancer Center 50

Samsung Medical Center 51

Clinical Trial Overview of Samsung Medical Center 51

Tohoku University 52

Clinical Trial Overview of Tohoku University 52

Kansai Hepatobiliary Oncology Group 53

Clinical Trial Overview of Kansai Hepatobiliary Oncology Group 53

National Cancer Center Hospital 54

Clinical Trial Overview of National Cancer Center Hospital 54

Washington University School of Medicine 55

Clinical Trial Overview of Washington University School of Medicine 55

The University of Tokyo 56

Clinical Trial Overview of The University of Tokyo 56

Mayo Clinic 57

Clinical Trial Overview of Mayo Clinic 57

Five Key Clinical Profiles 58

Appendix 88

Abbreviations 88

Definitions 88

Research Methodology 89

Secondary Research 89

About GlobalData 90

Contact Us 90

Disclaimer 90

Source 90

List of Figures

Bile Duct Cancer (Cholangiocarcinoma) Therapeutics, Global, Clinical Trials by Region (%), 2015* 7

Bile Duct Cancer (Cholangiocarcinoma) Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015* 8

Bile Duct Cancer (Cholangiocarcinoma) Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015* 9

Bile Duct Cancer (Cholangiocarcinoma) Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2015* 10

Bile Duct Cancer (Cholangiocarcinoma) Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2015* 11

Bile Duct Cancer (Cholangiocarcinoma) Therapeutics Clinical Trials, North America, Top Countries (%), 2015* 12

Proportion of Bile Duct Cancer (Cholangiocarcinoma) to Oncology Clinical Trials, G7 Countries (%), 2015* 15

Bile Duct Cancer (Cholangiocarcinoma) Therapeutics, G7 Countries, Clinical Trials by Phase, 2015* 16

Bile Duct Cancer (Cholangiocarcinoma) Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015* 17

Proportion of Bile Duct Cancer (Cholangiocarcinoma) to Oncology Clinical Trials, E7 Countries (%), 2015* 18

Bile Duct Cancer (Cholangiocarcinoma) Therapeutics, E7 Countries, Clinical Trials by Phase, 2015* 19

Bile Duct Cancer (Cholangiocarcinoma) Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2015* 20

Bile Duct Cancer (Cholangiocarcinoma) Therapeutics, Global, Clinical Trials by Phase (%), 2015* 21

Bile Duct Cancer (Cholangiocarcinoma) Therapeutics, Global, Clinical Trials In Progress by Phase, 2015* 22

Bile Duct Cancer (Cholangiocarcinoma) Therapeutics, Global, Clinical Trials by Trial Status, 2015* 23

Bile Duct Cancer (Cholangiocarcinoma) Therapeutics Clinical Trials, Global, by End Point Status, 2015* 24

Bile Duct Cancer (Cholangiocarcinoma) Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014 30

Bile Duct Cancer (Cholangiocarcinoma) Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2015* 31

Bile Duct Cancer (Cholangiocarcinoma) Therapeutics Clinical Trials, Global, Key Sponsors, 2015* 32

Bile Duct Cancer (Cholangiocarcinoma) Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015* 33

Bile Duct Cancer (Cholangiocarcinoma) Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015* 34

GlobalData Methodology 89

List of Tables

Bile Duct Cancer (Cholangiocarcinoma) Therapeutics, Global, Clinical Trials by Region, 2015* 7

Bile Duct Cancer (Cholangiocarcinoma) Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015* 8

Bile Duct Cancer (Cholangiocarcinoma) Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015* 9

Bile Duct Cancer (Cholangiocarcinoma) Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2015* 10

Bile Duct Cancer (Cholangiocarcinoma) Therapeutics Clinical Trials, Europe, Top Five Countries, 2015* 11

Bile Duct Cancer (Cholangiocarcinoma) Therapeutics Clinical Trials, North America, Top Countries, 2015* 12

Bile Duct Cancer (Cholangiocarcinoma) Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2015* 13

Bile Duct Cancer (Cholangiocarcinoma) Therapeutics Clinical Trials, Central and South America, Top Countries, 2015* 14

Proportion of Bile Duct Cancer (Cholangiocarcinoma) to Oncology Clinical Trials, G7 Countries (%), 2015* 15

Bile Duct Cancer (Cholangiocarcinoma) Therapeutics, G7 Countries, Clinical Trials by Phase, 2015* 16

Bile Duct Cancer (Cholangiocarcinoma) Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015* 17

Proportion of Bile Duct Cancer (Cholangiocarcinoma) to Oncology Clinical Trials, E7 Countries (%), 2015* 18

Bile Duct Cancer (Cholangiocarcinoma) Therapeutics, E7 Countries, Clinical Trials by Phase, 2015* 19

Bile Duct Cancer (Cholangiocarcinoma) Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2015* 20

Bile Duct Cancer (Cholangiocarcinoma) Therapeutics, Global, Clinical Trials by Phase, 2015* 21

Bile Duct Cancer (Cholangiocarcinoma) Therapeutics, Global, Clinical Trials In Progress by Phase 2015* 22

Bile Duct Cancer (Cholangiocarcinoma) Therapeutics, Global, Clinical Trials by Trial Status, 2015* 23

Bile Duct Cancer (Cholangiocarcinoma) Therapeutics Clinical Trials, Global, by End Point Status, 2015* 24

Bile Duct Cancer (Cholangiocarcinoma) Therapeutics, Global, Suspended Clinical Trials, 2015* 25

Bile Duct Cancer (Cholangiocarcinoma) Therapeutics, Global, Withdrawn Clinical Trials, 2015* 26

Bile Duct Cancer (Cholangiocarcinoma) Therapeutics, Global, Terminated Clinical Trials, 2015* 27

Bile Duct Cancer (Cholangiocarcinoma) Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014 30

Bile Duct Cancer (Cholangiocarcinoma) Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2015* 31

Bile Duct Cancer (Cholangiocarcinoma) Therapeutics Clinical Trials, Global, Key Sponsors, 2015* 32

Bile Duct Cancer (Cholangiocarcinoma) Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015* 33

Bile Duct Cancer (Cholangiocarcinoma) Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015* 34

Bile Duct Cancer (Cholangiocarcinoma) Therapeutics Clinical Trials Market, Global, Clinical Trials by Sanofi, 2015* 36

Bile Duct Cancer (Cholangiocarcinoma) Therapeutics Clinical Trials Market, Global, Clinical Trials by Eli Lilly and Company, 2015* 37

Bile Duct Cancer (Cholangiocarcinoma) Therapeutics Clinical Trials Market, Global, Clinical Trials by AstraZeneca PLC, 2015* 38

Bile Duct Cancer (Cholangiocarcinoma) Therapeutics Clinical Trials Market, Global, Clinical Trials by GlaxoSmithKline plc, 2015* 39

Bile Duct Cancer (Cholangiocarcinoma) Therapeutics Clinical Trials Market, Global, Clinical Trials by OncoTherapy Science, Inc., 2015* 40

Bile Duct Cancer (Cholangiocarcinoma) Therapeutics Clinical Trials Market, Global, Clinical Trials by Daiichi Sankyo Company, Limited, 2015* 41

Bile Duct Cancer (Cholangiocarcinoma) Therapeutics Clinical Trials Market, Global, Clinical Trials by CellAct Pharma GmbH, 2015* 42

Bile Duct Cancer (Cholangiocarcinoma) Therapeutics Clinical Trials Market, Global, Clinical Trials by C. H. Boehringer Sohn AG & Co. KG, 2015* 43

Bile Duct Cancer (Cholangiocarcinoma) Therapeutics Clinical Trials Market, Global, Clinical Trials by Astellas US Holding, Inc., 2015* 44

Bile Duct Cancer (Cholangiocarcinoma) Therapeutics Clinical Trials Market, Global, Clinical Trials by Agios Pharmaceuticals, Inc., 2015* 45

Bile Duct Cancer (Cholangiocarcinoma) Therapeutics Clinical Trials Market, Global, Clinical Trials by National Cancer Institute, 2015* 46

Bile Duct Cancer (Cholangiocarcinoma) Therapeutics Clinical Trials Market, Global, Clinical Trials by Massachusetts General Hospital, 2015* 49

Bile Duct Cancer (Cholangiocarcinoma) Therapeutics Clinical Trials Market, Global, Clinical Trials by Memorial Sloan Kettering Cancer Center, 2015* 50

Bile Duct Cancer (Cholangiocarcinoma) Therapeutics Clinical Trials Market, Global, Clinical Trials by Samsung Medical Center, 2015* 51

Bile Duct Cancer (Cholangiocarcinoma) Therapeutics Clinical Trials Market, Global, Clinical Trials by Tohoku University, 2015* 52

Bile Duct Cancer (Cholangiocarcinoma) Therapeutics Clinical Trials Market, Global, Clinical Trials by Kansai Hepatobiliary Oncology Group, 2015* 53

Bile Duct Cancer (Cholangiocarcinoma) Therapeutics Clinical Trials Market, Global, Clinical Trials by National Cancer Center Hospital, 2015* 54

Bile Duct Cancer (Cholangiocarcinoma) Therapeutics Clinical Trials Market, Global, Clinical Trials by Washington University School of Medicine, 2015* 55

Bile Duct Cancer (Cholangiocarcinoma) Therapeutics Clinical Trials Market, Global, Clinical Trials by The University of Tokyo, 2015* 56

Bile Duct Cancer (Cholangiocarcinoma) Therapeutics Clinical Trials Market, Global, Clinical Trials by Mayo Clinic, 2015* 57

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to query [@] kenresearch.com
 

Bile Duct Cancer (Cholangiocarcinoma) Clinical Trials, Trial Designs, Subjects Recruited, Unaccomplished Trials of Bile Duct Cancer (Cholangiocarcinoma), Pfizer, AstraZeneca, Novartis, GlaxoSmithKline, Sanofi, Eli Lilly and Company, Johnson & Johnson, Merck & Co., Inc, Bristol-Myers Squibb Company, Abbott Laboratories, Hoffmann-La Roche Ltd., Celgene Corporation, Daiichi Sankyo Company, Ltd., Bayer AG, Eisai Inc., GE Healthcare, Biogen Idec Inc., Copharos Inc., Wyeth Pharmaceuticals Inc., National Cancer Center, The University of Texas, M.D. Andersons, Vanderbilt Medical Center, Memorial Sloan Kettering Cancer Center, Cancer Research UK, North Central Cancer Group, Robert H. Lurie Comprehensive Cancer Center of Northwestern University, Fred Hutchinson Cancer Research Center, European Organization for Research and Treatment of Cancer, Dana-Farber Cancer Institute, The Cancer and Leukemia Group B, Columbia University, UCLA's Jonsson Comprehensive Cancer Center, Case Comprehensive Cancer Center, Mayo Clinic, Duke University, Ohio State University, National Cancer Center, University of Pennsylvania.

select a license

Single User License
USD 2500 INR 161400
Site License
USD 5000 INR 322800
Corporate User License
USD 7500 INR 484200

NEWSLETTER BY CATEGORY




Testimonials

The report sent to us was on the point, and its information was quite extensive, well structured, and well researched. More importantly what we valued was your response time and professionalism. As a leading global consulting firm, our clients expect high quality deliverables in short periods of time, so a reliable research partner is essential. For the price that you have charged the quality of your services were exceptional. We look forward to continue our relationship with your team on future engagements....

This is with regards to your report on India PVC pipes and fitting market outlook industry outlook to 2019. This is a very well written report and accept my compliments on the same.... ...

I am pleased to see the very useful and productive information in the report..Very well structured great presentation reflect professionalism in your research studies....

While we still are studying and analysing your reports about Vietnam & Thailand, we would like to convey to your research team that they have done a very good job in compiling so much of information together. We hope to see more of such well researched reports. All the best & keep it up. ...

We would like to appreciate Ken Research for their great efforts and wonderful support in providing the Market Intelligence Report for ITPC. The information, statistics and research are well understandable and very clear to the point. We are happy with Ken research for their good client service, on-time delivery of the report and as said the report itself. Thank you Ken research for bringing the valuable output for us. We would be looking forward to have more research with you in the near future. Wish you a success in your business!...



Related Products in vertical
Ken Research Pvt. Ltd. Unit 14, Tower B3, Spaze I Tech Business Park, Sohna Road, sector 49
     Gurgaon, Haryana - 122001, India

download

Company Brochure

Engage with Us

query [@] kenresearch.com